Surgical Treatments of Chinese Patients with Lung Malignant Tumors.
Hu Liao,Xiaofei Li,Heng Zhao,Xiangning Fu,Yang Liu,Jian Hu,Yin Li,Feng Jiang,Daqiang Sun,Deruo Liu,Haiying Yang,Jiandong Mei,Chenglin Guo,Qiang Pu,Lin Ma,Feng Lin,Yunke Zhu,Guowei Che,Yidan Lin,Lunxu Liu
DOI: https://doi.org/10.1200/jco.2018.36.15_suppl.e20525
IF: 45.3
2018-01-01
Journal of Clinical Oncology
Abstract:e20525 Background: Lung cancer is the leading cause of cancer related deaths in China. Along with rapid development of new technologies, the modes of surgeries are experiencing changes. The purposes of the study are to investigate the status quo of surgical operations in Chinese patients. Methods: The study data on the patients with lung cancer (≥ 18 years) who received surgeries in the top 10 study sites from 2014 to 2017 were collected from the collaborative prospective LinkDoc database. The overall survial (OS) was measured based on the method of propensity score matching. Results: A total of 21,772 patients (ratio of male/female: 1.3, 71.7% adenocarcinoma) were recruited. Of all, 59.8% of subjects were non-smokers. The majority of patients (71.4%) were performed with minimally invasive thoracic surgeries (MITS) and most subjects with surgeries were early-stage patients (Ia:47.2%;Ib:14.9%). The percentages of patients with post-operative complications and patients with 30-day mortality rate were 6.5% and 0.54%, respectively. The 1-, 2-, and 3-year OS rates (94.9%, 87.1%, 78.9%) of the patients with MITS were significantly higher than those of the patients (88.1%, 76.2%, 66.5%) with thoracotomy (p < 0.01) (Table 1). Conclusions: In the Chinese patients with surgeries, the proportions of females, non-smokers, early-stage patients, and patients with adenocarcinoma are increasing. The minimally invasive thoracic surgeries have been well developed and performed without compromising perioperative morbidity and mortality. The patients with MITS were observed with better survival benefits compared to those patients with thoractomy within the short follow-up observation period. Clinical trial information: NCT03421093.Table 1 Clinical characteristics of patients with surgeries Parameters Clinical data Gender (%) Male 56.5% Female 43.5% Age (years) 59.3±9.8 Smoking history (%) Non-smoking 59.8% Smoking 20.0% Ever smoked 20.2% Pathological type (%) Adenocarcinoma 71.7% TNM stage (%) Ia 47.2% Ib 14.9% Modes of surgeries (%) Thoracotomy 24.8% VATS 70.0% VATS (Conversion) 3.7% RATS 1.4% Surgical operations Surgical duration (minutes) 152.8±69 Lymph nodes dissection (number) 13.3±9.77 Postoperative stay (days) 9.1±6.16 Perioperative morbidity (%) 6.5% 30-day mortality (%) 0.54%